IRIS
TETI, ANNA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.010
EU - Europa 4.629
AS - Asia 3.154
SA - Sud America 276
AF - Africa 22
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.102
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.985
IE - Irlanda 1.173
CN - Cina 1.060
SE - Svezia 775
SG - Singapore 726
TR - Turchia 672
HK - Hong Kong 576
DE - Germania 535
RU - Federazione Russa 519
IT - Italia 430
UA - Ucraina 384
GB - Regno Unito 376
BR - Brasile 256
FI - Finlandia 201
FR - Francia 137
BE - Belgio 30
IN - India 29
VN - Vietnam 21
NL - Olanda 16
CZ - Repubblica Ceca 12
JP - Giappone 12
CA - Canada 11
AT - Austria 10
IQ - Iraq 9
MA - Marocco 8
MX - Messico 8
IL - Israele 7
AR - Argentina 6
AU - Australia 6
UZ - Uzbekistan 6
EG - Egitto 5
ZA - Sudafrica 5
AZ - Azerbaigian 4
BG - Bulgaria 4
LT - Lituania 4
BD - Bangladesh 3
CL - Cile 3
EC - Ecuador 3
ES - Italia 3
JO - Giordania 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
PE - Perù 3
PK - Pakistan 3
TW - Taiwan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BN - Brunei Darussalam 2
EU - Europa 2
GR - Grecia 2
KR - Corea 2
LB - Libano 2
MK - Macedonia 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
CI - Costa d'Avorio 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
HN - Honduras 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PL - Polonia 1
PR - Porto Rico 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 15.102
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.497
Chandler 1.288
Dublin 1.170
Hong Kong 574
Boardman 533
Santa Clara 434
Singapore 327
Izmir 321
San Mateo 301
Nanjing 280
Wilmington 277
Lawrence 201
Princeton 201
New York 196
Ann Arbor 140
Moscow 122
Woodbridge 110
Ashburn 105
Milan 96
Nanchang 92
Shenyang 87
Seattle 85
L'aquila 69
Mountain View 67
Des Moines 66
Verona 60
Tianjin 58
Falls Church 57
Beijing 56
Hebei 47
Bremen 43
Jiaxing 43
Kunming 43
L’Aquila 41
Shanghai 41
Los Angeles 36
Rome 35
Dearborn 34
Kitzingen 33
Ningbo 31
Changsha 28
Philadelphia 27
Jinan 26
The Dalles 26
Guangzhou 25
Norwalk 25
Brussels 24
Zhengzhou 21
Helsinki 20
Dallas 18
Dong Ket 18
Pune 17
Nuremberg 15
São Paulo 15
Fremont 14
Munich 13
Tappahannock 13
Brno 12
Houston 12
Lanzhou 12
Taizhou 12
Pescara 11
Düsseldorf 9
Hangzhou 9
Aquila 8
Auburn Hills 8
Fuzhou 8
Strasbourg 8
Tokyo 8
Changchun 7
Rio de Janeiro 7
Belo Horizonte 6
Fairfield 6
Hefei 6
Redwood City 6
Washington 6
West Jordan 6
Brasília 5
Council Bluffs 5
Istanbul 5
Lappeenranta 5
London 5
Mexico City 5
Paris 5
Redmond 5
Tashkent 5
Toronto 5
Würzburg 5
Baku 4
Chongqing 4
Falkenstein 4
Frankfurt am Main 4
Ghent 4
Ipatinga 4
Shangdi 4
Turku 4
Vienna 4
Xian 4
Adelaide 3
Amsterdam 3
Totale 9.910
Salva come PNG Salva come JPEG
Nome #
SMALL INTERFERING RNA (siRNA) PER LA TERAPIA DELL’OSTEOPETROSI AUTOSOMICA DOMINANTE DI TIPO 2 (ADO2) CAUSATA DA MUTAZIONE DEL GENE CLCN7 (ADO2 CLCN7-DIPENDENTE) 155
Osteoclast-poor human osteopetrosis due to mutations in RANKL 146
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression 120
Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis 117
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases 115
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation 112
CALCITONIN DOWN-REGULATES IMMEDIATE CELL SIGNALS INDUCED IN HUMAN OSTEOCLAST-LIKE CELLS BY THE BONE SIALOPROTEIN-IIA FRAGMENT THROUGH A POSTINTEGRIN RECEPTOR MECHANISM 105
Oligodeoxynucleotide targeted to the alpha(v) gene inhibits alpha(v) integrin synthesis, impairs osteoclast function, and activates intracellular signals to apoptosis 104
Interleukin-1β, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk 103
Anabolic and antiresorptive modulation of bone homeostasis by the epigenetic modulator sulforaphane, a naturally occurring isothiocyanate 102
The role of the AlphaVbeta3 integrin in the development of osteolytic bone metastases: A pharmacological target for alternative therapy? 99
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development 99
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 96
Osteoplastic activity of mature osteocytes evaluated by H-proline incorporation. 95
The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro 95
The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling 93
An antisense oligonucleotide targeting the alpha V integrin gene inhibits adhesion and induces apoptosis in breast cancer cells 92
Modulation of estrogen receptor levels in mouse uterus by protein kinase C isoenzymes 92
Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models 91
Osteoclast isolation: New developments and methods 91
Ultrastructural study of human adrenal pheochromocytoma by open needle biopsy. 90
P2RX7 Purinoceptor: A Therapeutic Target for Ameliorating the Symptoms of Duchenne Muscular Dystrophy 90
c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling 90
The "love-hate" relationship between osteoclasts and bone matrix 90
Transient estrogen exposure of female mice during early development permanently affects osteoclastogenesis in adulthood 89
Bone cells and the mechanisms of bone remodelling 89
SMALL INTERFERING RNA (siRNA) FOR THE THERAPY OF TYPE 2 (ADO2) AUTOSOMAL DOMINANT OSTEOPETROSIS CAUSED BY CLCN7 (ADO2 CLCN7-DEPENDENT) GENE MUTATION 89
A COMPLEX ROLE FOR LIPOCALIN 2 IN BONE METABOLISM: GLOBAL ABLATION IN MICE INDUCES OSTEOPENIA CAUSED BY AN ALTERED ENERGY METABOLISM 89
Characterization of the osteoblast-like cell phenotype under microgravity conditions in the NASA-approved Rotating Wall Vessel bioreactor (RWV) 88
Bone metastasis: pathogenesis and therapeutic implications 88
Tyrosine kinase Src inhibitors: Potential therapeutic applications 88
PLEKHM1 is involved in osteoclastic vesicular transport and mutations in this gene cause osteopetrosis in incisors absent rat and human 88
Inhibition of protein kinase c-src reduces the incidence of breast cancer metastases and increases survival in mice: Implications for therapy 88
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis 87
The C-terminal domain of chondroadherin: a new regulator of osteoclast motility counteracting bone loss 87
Signaling in osteoblasts integrates bone remodeling and energy metabolism 87
Melanoma cells stimulate osteoclastogenesis, c-src expression and osteoblast cytokines 87
Apoptosis-associated speck-like protein containing a caspase-1 recruitment domain (ASC) contributes to osteoblast differentiation and osteogenesis 87
Differentially expressed genes in autosomal dominant osteopetrosis type II osteoclasts reveal known and novel pathways for osteoclast biology 86
OSTEOCLAST CYTOSOLIC CALCIUM, REGULATED BY VOLTAGE-GATED CALCIUM CHANNELS AND EXTRACELLULAR CALCIUM, CONTROLS PODOSOME ASSEMBLY AND BONE-RESORPTION 86
Global Transcriptome Analysis in Mouse Calvarial Osteoblasts Highlights Sets of Genes Regulated by Modeled Microgravity and Identifies A "Mechanoresponsive Osteoblast Gene Signature" 86
Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases 86
Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells 85
A six-gene signature predicting breast cancer lung metastasis 85
Congenital disorders of bone and blood 85
Receptor Activator of NF-kappa B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147 84
The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: A preclinical study 84
Protein kinase C modulates estrogen receptors in differentiated osteoblastic cells in vitro 84
Decreased c-Src expression enhances osteoblast differentiation and bone formation 84
Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2 84
Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent 83
Kinase-dependent and independent role of EphA2 in the regulation of prostate cancer invasion and metastasis 83
Colony stimulating factor-1-induced osteoclast spreading depends on substrate and requires the vitronectin receptor and the c-src proto-oncogene 83
Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders 83
A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in chinese hamster ovary (CHO) cells 83
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro 82
Transforming growth factor-beta enhances adhesion of melanoma cells to the endothelium in vitro 82
Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and Matrigel invasion 82
Association of intermediate osteopetrosis with poikiloderma 82
ROUS-SARCOMA VIRUS-TRANSFORMED FIBROBLASTS AND CELLS OF MONOCYTIC ORIGIN DISPLAY A PECULIAR DOT-LIKE ORGANIZATION OF CYTOSKELETAL PROTEINS INVOLVED IN MICROFILAMENT MEMBRANE INTERACTIONS 82
Type II benign osteopetrosis (Albers-Schonberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations 81
Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo [2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway 81
Interaction of estrogen receptor a with protein kinase C alpha and c-Src in osteoblasts during differentiation 81
THE EFFECTS OF PARATHYROID-HORMONE OR 1,25-DIHYDROXYVITAMIN-D3 ON MONOCYTE-OSTEOCLAST FUSION 81
Effects of advanced glycation end products on cytosolic Ca2+ signaling of cultured human mesangial cells 81
Non-conventional role of haemoglobin beta in breast malignancy 81
Apparent cure of a newborn with malignant osteopetrosis using prednisone therapy 81
Influence of calcium depletion on medullary bone of laying hens. 80
EFFECTS OF CALCIUM-PHOSPHATE-BASED MATERIALS ON PROLIFERATION AND ALKALINE-PHOSPHATASE ACTIVITY OF NEWBORN RAT PERIOSTEAL CELLS-INVITRO 80
Immediate cell signal induced by laminin in rat Sertoli cells 80
Microgravity induces apoptosis and increases interleukin 6 expression in osteoblast-like cells. 80
Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone 80
Cell-substratum interaction of cultured avian osteoclasts is mediated by specific adhesion structures. 79
OSTEOBLAST-OSTEOCLAST RELATIONSHIPS IN BONE-RESORPTION - OSTEOBLASTS ENHANCE OSTEOCLAST ACTIVITY IN A SERUM-FREE COCULTURE SYSTEM 79
beta-Arrestin2 Regulates RANKL and Ephrins Gene Expression in Response to Bone Remodeling in Mice 79
the effect of microgravity on osteoblast metabolism 79
An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6 79
The Great Beauty of the osteoclast 78
NEW MODEL FOR BONE-RESORPTION STUDY IN-VITRO - HUMAN OSTEOCLAST-LIKE CELLS FROM GIANT-CELL TUMORS OF BONE 78
Kinome profiling of osteoblasts on hydroxyapatite opens new avenues on biomaterial cell signaling 78
CALCITONIN INCREASES CYTOSOLIC-FREE CALCIUM-CONCENTRATION VIA CAPACITATIVE CALCIUM INFLUX 78
Recent advances in mesenchymal stem cell immunomodulation. The role of microvesicles 77
Monocytes from circulating blood fuse in vitro with purified osteoclasts in primary culture. 77
beta 1 Integrin antisense oligodeoxynucleotides: utility in controlling osteoclast function 77
CALCIUM RELEASE-ACTIVATED CALCIUM INFLUX IN CULTURED HUMAN MESANGIAL CELLS 77
Mature osteocytes behaviour in a repletion period: the occurrence of osteoplastic activity. 77
Imbalance of osteoclastogenesis-regulating factors in celiac disease 77
Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells 77
Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio 76
Tartronates: A new generation of drugs affecting bone metabolism 76
Increase in cytosolic Ca2+ induced by elevation of extracellular Ca2+ in skeletal myogenic cells 76
Anti-osteoblastogenic, pro-inflammatory and pro-angiogenic effect of extracellular vesicles isolated from the human osteosarcoma cell line MNNG/HOS 76
Impaired skeletal development in interleukin-6 transgenic mice. A model for the impact of chronic inflammation on the growing skeletal system 75
REGULATION OF CELLULAR FUNCTIONS BY EXTRACELLULAR-MATRIX 75
Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine 75
Lipocalin 2: A New Mechanoresponding Gene Regulating Bone Homeostasis 75
Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: A new biological and clinical parameter for prostatic carcinoma 74
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice 74
A novel calcium sensor stimulating inositol phosphate formation and [Ca2+](i) signaling expressed by GCT23 osteoclast-like cells 74
Chronic inflammatory intestinal diseases and bone loss 74
Totale 8.670
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.744
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020203 0 0 0 0 0 0 0 0 0 0 4 199
2020/20211.726 44 222 1 195 194 89 199 15 206 93 363 105
2021/20221.438 89 136 343 91 62 39 33 83 103 26 77 356
2022/20233.649 285 188 69 368 349 419 5 279 1.499 14 116 58
2023/2024922 125 53 66 163 60 264 17 21 5 30 12 106
2024/20253.242 53 51 319 135 457 345 529 313 852 176 12 0
Totale 15.255